Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States.

Steinau M, Saraiya M, Goodman MT, Peters ES, Watson M, Cleveland JL, Lynch CF, Wilkinson EJ, Hernandez BY, Copeland G, Saber MS, Hopenhayn C, Huang Y, Cozen W, Lyu C, Unger ER. Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Emerg Infect Dis. 2014 May; 20(5):822-8.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Alphapapillomavirus
Female
Humans
Male
Middle Aged
Oropharyngeal Neoplasms
Papillomavirus Infections
Papillomavirus Vaccines
Prevalence
Registries
United States

authors with profiles

Brenda Y. Hernandez,PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support